Kalunga Muya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kalunga Muya has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
M. Kalonji
Laboratoire de pharmacognosie, faculté des sciences pharmaceutiques, université de Lubumbashi (UNILU), 27, avenue Kato, Commune Kampemba, Lubumbashi, République démocratique du Congo
3 shared publications- Marsi Mbayo Kitambala
Department of Chemistry and Industries, Faculty of Sciences and Technology, University of Lubumbashi (UNILU), Lubumbashi, Democratic Republic of the Congo
3 shared publications A. Kaponda
Laboratoire de biologie clinique, faculté des sciences pharmaceutiques, UNILU, 27, avenue Kato, Commune Kampemba, Lubumbashi, République démocratique du Congo
2 shared publications- Evodie Numbi Wa Ilunga
Department of Pharmacology, Faculty of Pharmaceutical Sciences, University of Lubumbashi (UNILU), Lubumbashi, Democratic Republic of the Congo
2 shared publications - J. B. S. Lumbu
Laboratoire de chimie organique et substances naturelles, Faculté des Sciences, Sépartement de Chimie, Université de Lubumbashi, République Démocratique du Congo
2 shared publications L. Simbi
Laboratoire de chimie organique, faculté des sciences, université de Lubumbashi, 02, avenue de la Maternité, Commune Lubumbashi, Lubumbashi, République démocratique du Congo
2 shared publications
Latest Publications
- Open Access
- 3 May 2025
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 53 (1) , 1-13
Ethnobotanical survey and antimycobacterial activities of plants used against tuberculosis in Lubumbashi, DR Congo
Background: Tuberculosis is still a serious threat to public health in Africa and especially in the Democratic Republic of Congo, which is one of the eight countries with approximately two-thirds of the global cases of tuberculosis. Given the difficulties in accessing health care services and antitubercular treatments, indigenous population also uses plant-based traditional medicine. This study aimed to identify plants with antituberculosis potential in traditional Katangese medicine. Methods: Interviews were conducted on traditional healers using snowball sampling method. Ethnobotanical data were assessed by determination of the informant consensus factor and the relative frequency of citation. Guided field walks allowed to collect plants. Methanolic extracts were tested on Mycobacterium smegmatis and Mycobacterium bovis BCG using microdilution, diffusion and agar proportion methods. The cytotoxicity of the best extracts was evaluated by cell viability assay on the human cervical squamous carcinoma SiHa cell line. The 50% inhibitory concentration and minimal inhibitory concentration (MIC) were used to determine the selectivity index. Results: Thirty-eight plant species from 23 families were identified, most of which were from Fabaceae (16%). Eleven out of 17 plant extracts inhibited the growth of M. smegmatis at MIC ranging from 13 to 250 μg/mL. The methanolic extracts of Zanthoxylum chalybeum and Parinari curatellifolia showed MIC99 of 62.5 and 62.5–125 μg/mL, respectively, on M. bovis BCG and showed IC50 values of 28 and 20 μg/mL, respectively suggesting a low selectivity index. This study was the first to investigate the antimycobacterial activity of Terminalia mollis, Phyllanthus muellerianus, Ochna afzelii, and Rothmannia engleriana. Conclusions: The demonstration of antimycobacterial activity in the plants used in Lubumbashi against tuberculosis opens opportunities for more in-depth research into their chemical composition and toxicity, ultimately aiming to enhance their safety for treatment of tuberculosis.
- 3 May 2025
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 53 (1) , 1-13
Open AccessEthnobotanical survey and antimycobacterial activities of plants used against tuberculosis in Lubumbashi, DR Congo
Background: Tuberculosis is still a serious threat to public health in Africa and especially in the Democratic Republic of Congo, which is one of the eight countries with approximately two-thirds of the global cases of tuberculosis. Given the difficulties in accessing health care services and antitubercular treatments, indigenous population also uses plant-based traditional medicine. This study aimed to identify plants with antituberculosis potential in traditional Katangese medicine. Methods: Interviews were conducted on traditional healers using snowball sampling method. Ethnobotanical data were assessed by determination of the informant consensus factor and the relative frequency of citation. Guided field walks allowed to collect plants. Methanolic extracts were tested on Mycobacterium smegmatis and Mycobacterium bovis BCG using microdilution, diffusion and agar proportion methods. The cytotoxicity of the best extracts was evaluated by cell viability assay on the human cervical squamous carcinoma SiHa cell line. The 50% inhibitory concentration and minimal inhibitory concentration (MIC) were used to determine the selectivity index. Results: Thirty-eight plant species from 23 families were identified, most of which were from Fabaceae (16%). Eleven out of 17 plant extracts inhibited the growth of M. smegmatis at MIC ranging from 13 to 250 μg/mL. The methanolic extracts of Zanthoxylum chalybeum and Parinari curatellifolia showed MIC99 of 62.5 and 62.5–125 μg/mL, respectively, on M. bovis BCG and showed IC50 values of 28 and 20 μg/mL, respectively suggesting a low selectivity index. This study was the first to investigate the antimycobacterial activity of Terminalia mollis, Phyllanthus muellerianus, Ochna afzelii, and Rothmannia engleriana. Conclusions: The demonstration of antimycobacterial activity in the plants used in Lubumbashi against tuberculosis opens opportunities for more in-depth research into their chemical composition and toxicity, ultimately aiming to enhance their safety for treatment of tuberculosis.
- Open Access
- 25 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2528
Unraveling the Complexity of Vaso-Occlusive Crises in Sickle Cell Disease: Insights from a Resource-Limited Setting
Background/Objectives: This study investigated vaso-occlusive crises (VOCs) in sickle cell disease in Lubumbashi, Democratic Republic of Congo, aiming to understand the disease complexities amidst limited resources. With sickle cell hemoglobinopathies on the rise in sub-Saharan Africa, this nine-year study explored factors associated with VOCs and hematological components. Methods: This study comprised 838 patients, analyzing VOCs and hematological changes over time. Demographic characteristics and blood composition changes were carefully categorized. A total of 2910 crises were observed and managed, with analyses conducted on severity, localization, and age groups using statistical methods. Results: The majority of crises were mild or moderate, primarily affecting osteoarticular regions. Statistical analysis revealed significant disparities in crisis intensity based on location and age. The association between blood samples and the number of comorbidities was investigated. Significant positive associations were found for all parameters, except monocytes, indicating a potential link between blood variables and complication burden. Survival analysis using Cox regression was performed to predict the probability of experiencing a second crisis. No significant effects of medication or localization were observed. However, intensity (p < 0.001), age (p < 0.001), and gender (p < 0.001) showed significant effects. Adjusted Hazard Ratios indicated increased risk with age and male gender and reduced risk with mild or severe crisis intensity compared to light. Conclusions: This research sheds light on the complexities of VOCs in resource-limited settings where sickle cell disease is prevalent. The intricate interplay between clinical, laboratory, and treatment factors is highlighted, offering insights for improved patient care. It aims to raise awareness of patient challenges and provide valuable information for targeted interventions to alleviate their burden.
- 25 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2528
Open AccessUnraveling the Complexity of Vaso-Occlusive Crises in Sickle Cell Disease: Insights from a Resource-Limited Setting
Background/Objectives: This study investigated vaso-occlusive crises (VOCs) in sickle cell disease in Lubumbashi, Democratic Republic of Congo, aiming to understand the disease complexities amidst limited resources. With sickle cell hemoglobinopathies on the rise in sub-Saharan Africa, this nine-year study explored factors associated with VOCs and hematological components. Methods: This study comprised 838 patients, analyzing VOCs and hematological changes over time. Demographic characteristics and blood composition changes were carefully categorized. A total of 2910 crises were observed and managed, with analyses conducted on severity, localization, and age groups using statistical methods. Results: The majority of crises were mild or moderate, primarily affecting osteoarticular regions. Statistical analysis revealed significant disparities in crisis intensity based on location and age. The association between blood samples and the number of comorbidities was investigated. Significant positive associations were found for all parameters, except monocytes, indicating a potential link between blood variables and complication burden. Survival analysis using Cox regression was performed to predict the probability of experiencing a second crisis. No significant effects of medication or localization were observed. However, intensity (p < 0.001), age (p < 0.001), and gender (p < 0.001) showed significant effects. Adjusted Hazard Ratios indicated increased risk with age and male gender and reduced risk with mild or severe crisis intensity compared to light. Conclusions: This research sheds light on the complexities of VOCs in resource-limited settings where sickle cell disease is prevalent. The intricate interplay between clinical, laboratory, and treatment factors is highlighted, offering insights for improved patient care. It aims to raise awareness of patient challenges and provide valuable information for targeted interventions to alleviate their burden.
- 1 May 2021
- Published by Elsevier in Annales Pharmaceutiques Françaises
- Vol. 79 (3) , 308-323
Toxicité aiguë et subaiguë de Garcinia huillensis Baker, plante utilisée contre la schistosomiase urogénitale dans le Haut-Katanga, RD Congo
- 1 May 2021
- Published by Elsevier in Annales Pharmaceutiques Françaises
- Vol. 79 (3) , 308-323
Toxicité aiguë et subaiguë de Garcinia huillensis Baker, plante utilisée contre la schistosomiase urogénitale dans le Haut-Katanga, RD Congo
- 1 March 2019
- Published by Elsevier in Le Pharmacien Hospitalier et Clinicien
- Vol. 54 (1) , 49-55
Étude de la conformité formelle des prescriptions médicales dans un milieu hospitalier, cas des cliniques universitaires de Lubumbashi
- 1 March 2019
- Published by Elsevier in Le Pharmacien Hospitalier et Clinicien
- Vol. 54 (1) , 49-55
Étude de la conformité formelle des prescriptions médicales dans un milieu hospitalier, cas des cliniques universitaires de Lubumbashi
- 1 April 2018
- Published by JLE in Phytotherapie
- Vol. 16 (2) , 74-86
Test d'activité antimitotique et étude chimique préliminaire de quelques Euphorbiaceae du Katanga méridional (RDC)
Le criblage chimique a permis de mettre en évidence les alcaloïdes (29,8 % des résultats positifs sur les 104 tests réalisés pour la recherche de ce groupe), les flavonoïdes (87,5 %), les quinones (23,0 %), les anthocyanes (82,7 %), les saponines (95,2 %), les stéroïdes (87,5 %), les tanins (93,3 %) et les terpénoïdes (61,5 %). Les tests d’activité antimitotique ont révélé que les extraits bruts aqueux et méthanoliques des espèces étudiées ont manifesté un effet antimitotique sur la germination des graines de Sorghum sp. En effet, les extraits aqueux de 20 espèces et les extraits méthanoliques de 28 espèces étudiées, par leur concentration inhibitrice située entre 1 et 0,78 mg/ml, leur taux d’inhibition se situant entre 6,7–100 % et leur indice de mitose inférieure à 1, ont inhibé plus efficacement la germination de graines de Sorghum sp plus que la colchicine (6,7 % à 2,5 mg/ml) et le méthotrexate (6,7 % à 5 mg/ml), utilisées comme substances de référence. The chemical screening allowed to highlight alkaloids (29.8% of positive results on 104 tests for the research of this group), flavonoids (87.5%), quinones (23.0%), anthocyanins (82.7%), saponins (95.2%), steroids (87.5%), tannins (93.3%), and terpenoids (61.5%). The antimitotic activity tests revealed that the aqueous and methanolic crude extracts of the species studied showed an antimitotic effect on the germination of Sorghum sp. seeds. Indeed, the aqueous extracts of 20 species and methanolic extracts of 28 species tested, with their minimal inhibitory concentration between 1 and 0.78 mg/ml, their inhibition rates ranging from 6.7 to 100%, and mitotic index below 1, more effectively inhibited the germination of seeds of Sorghum sp. more than colchicine (6.7% to 2.5 mg/ml) and methotrexate (6.7% at 5 mg/ml), used as controls.
- 1 April 2018
- Published by JLE in Phytotherapie
- Vol. 16 (2) , 74-86
Test d'activité antimitotique et étude chimique préliminaire de quelques Euphorbiaceae du Katanga méridional (RDC)
Le criblage chimique a permis de mettre en évidence les alcaloïdes (29,8 % des résultats positifs sur les 104 tests réalisés pour la recherche de ce groupe), les flavonoïdes (87,5 %), les quinones (23,0 %), les anthocyanes (82,7 %), les saponines (95,2 %), les stéroïdes (87,5 %), les tanins (93,3 %) et les terpénoïdes (61,5 %). Les tests d’activité antimitotique ont révélé que les extraits bruts aqueux et méthanoliques des espèces étudiées ont manifesté un effet antimitotique sur la germination des graines de Sorghum sp. En effet, les extraits aqueux de 20 espèces et les extraits méthanoliques de 28 espèces étudiées, par leur concentration inhibitrice située entre 1 et 0,78 mg/ml, leur taux d’inhibition se situant entre 6,7–100 % et leur indice de mitose inférieure à 1, ont inhibé plus efficacement la germination de graines de Sorghum sp plus que la colchicine (6,7 % à 2,5 mg/ml) et le méthotrexate (6,7 % à 5 mg/ml), utilisées comme substances de référence. The chemical screening allowed to highlight alkaloids (29.8% of positive results on 104 tests for the research of this group), flavonoids (87.5%), quinones (23.0%), anthocyanins (82.7%), saponins (95.2%), steroids (87.5%), tannins (93.3%), and terpenoids (61.5%). The antimitotic activity tests revealed that the aqueous and methanolic crude extracts of the species studied showed an antimitotic effect on the germination of Sorghum sp. seeds. Indeed, the aqueous extracts of 20 species and methanolic extracts of 28 species tested, with their minimal inhibitory concentration between 1 and 0.78 mg/ml, their inhibition rates ranging from 6.7 to 100%, and mitotic index below 1, more effectively inhibited the germination of seeds of Sorghum sp. more than colchicine (6.7% to 2.5 mg/ml) and methotrexate (6.7% at 5 mg/ml), used as controls.
- 1 February 2018
- Published by Elsevier in Revue de Pneumologie Clinique
- Vol. 74 (1) , 9-15
Prévalence de la co-infection VIH-tuberculose et impact du VIH sur les tuberculeux dans la zone de santé de Lubumbashi de 2014 à 2015
- 1 February 2018
- Published by Elsevier in Revue de Pneumologie Clinique
- Vol. 74 (1) , 9-15
Prévalence de la co-infection VIH-tuberculose et impact du VIH sur les tuberculeux dans la zone de santé de Lubumbashi de 2014 à 2015
- 26 August 2016
- Published by JLE in Phytotherapie
- p. 1-13
Test d’activité antimitotique et étude chimique préliminaire de quelques Euphorbiaceae du Katanga méridional (RDC)
Le criblage chimique a permis de mettre en évidence les alcaloïdes (29,8 % des résultats positifs sur les 104 tests réalisés pour la recherche de ce groupe), les flavonoïdes (87,5 %), les quinones (23,0 %), les anthocyanes (82,7 %), les saponines (95,2 %), les stéroïdes (87,5 %), les tanins (93,3 %) et les terpénoïdes (61,5 %). Les tests d’activité antimitotique ont révélé que les extraits bruts aqueux et méthanoliques des espèces étudiées ont manifesté un effet antimitotique sur la germination des graines de Sorghum sp. En effet, les extraits aqueux de 20 espèces et les extraits méthanoliques de 28 espèces étudiées, par leur concentration inhibitrice située entre 1 et 0,78 mg/ml, leur taux d’inhibition se situant entre 6,7–100 % et leur indice de mitose inférieure à 1, ont inhibé plus efficacement la germination de graines de Sorghum sp plus que la colchicine (6,7 % à 2,5 mg/ml) et le méthotrexate (6,7 % à 5 mg/ml), utilisées comme substances de référence.
- 26 August 2016
- Published by JLE in Phytotherapie
- p. 1-13
Test d’activité antimitotique et étude chimique préliminaire de quelques Euphorbiaceae du Katanga méridional (RDC)
Le criblage chimique a permis de mettre en évidence les alcaloïdes (29,8 % des résultats positifs sur les 104 tests réalisés pour la recherche de ce groupe), les flavonoïdes (87,5 %), les quinones (23,0 %), les anthocyanes (82,7 %), les saponines (95,2 %), les stéroïdes (87,5 %), les tanins (93,3 %) et les terpénoïdes (61,5 %). Les tests d’activité antimitotique ont révélé que les extraits bruts aqueux et méthanoliques des espèces étudiées ont manifesté un effet antimitotique sur la germination des graines de Sorghum sp. En effet, les extraits aqueux de 20 espèces et les extraits méthanoliques de 28 espèces étudiées, par leur concentration inhibitrice située entre 1 et 0,78 mg/ml, leur taux d’inhibition se situant entre 6,7–100 % et leur indice de mitose inférieure à 1, ont inhibé plus efficacement la germination de graines de Sorghum sp plus que la colchicine (6,7 % à 2,5 mg/ml) et le méthotrexate (6,7 % à 5 mg/ml), utilisées comme substances de référence.
- 2 August 2014
- Published by JLE in Phytotherapie
- Vol. 12 (4) , 213-228
Survol ethnobotanique de quelques plantes utilisées contre la schistosomiase urogénitale à Lubumbashi et environs
Afin de contribuer à l’inventaire des plantes médicinales utilisées contre la schistosomiase urogénitale à Lubumbashi et ses environs, une enquête ethnobotanique a été entreprise auprès de 43 tradipraticiens. Elle a permis d’inventorier 61 espèces utilisées contre la schistosomiase urogénitale. Ces espèces sont contenues dans 32 familles et appartiennent à 55 genres différents. Il a été aussi dégagé que ces mêmes espèces végétales sont aussi utilisées dans 37 autres indications dont les vers intestinaux et le paludisme. Diverses parties de ces plantes (écorces de racine et de tige, feuilles, fruits, graines, rhizomes et tubercules) servent par divers modes de préparation (décoction, infusion, macération, expression, pulvérisation) à confectionner diverses recettes. Plusieurs modes d’administration sont exploités : boisson, application locale, bain de vapeur, instillations buccales, nasales, vaginales et lavement. La voie orale reste le mode d’administration le plus exploité. For contributing to the assemblage of medicinal plants used against schistosomiasis in Lubumbashi and nearby, a survey was piloted in this area. This ethnobotanic survey involving 43 respondents permitted us to collect information about 61 plants used as anti-schistosomal. These species belong to 55 different genuses distributed among 32 families. The result allows us to know that these anti-schistosomial species are also used in 37 indications, including intestinal worms and malaria. Many parts of these species (bark of roots and stalks, leaves, fruits, seeds, rhizomes) are used in different manners (decoction, infusion, maceration, powder) to make different doses. Different manners of taking prepared medicines are employed: drinking, local application, painting, vapor bath, purgative. Drinking the product remains the most common way of administration.
- 2 August 2014
- Published by JLE in Phytotherapie
- Vol. 12 (4) , 213-228
Survol ethnobotanique de quelques plantes utilisées contre la schistosomiase urogénitale à Lubumbashi et environs
Afin de contribuer à l’inventaire des plantes médicinales utilisées contre la schistosomiase urogénitale à Lubumbashi et ses environs, une enquête ethnobotanique a été entreprise auprès de 43 tradipraticiens. Elle a permis d’inventorier 61 espèces utilisées contre la schistosomiase urogénitale. Ces espèces sont contenues dans 32 familles et appartiennent à 55 genres différents. Il a été aussi dégagé que ces mêmes espèces végétales sont aussi utilisées dans 37 autres indications dont les vers intestinaux et le paludisme. Diverses parties de ces plantes (écorces de racine et de tige, feuilles, fruits, graines, rhizomes et tubercules) servent par divers modes de préparation (décoction, infusion, macération, expression, pulvérisation) à confectionner diverses recettes. Plusieurs modes d’administration sont exploités : boisson, application locale, bain de vapeur, instillations buccales, nasales, vaginales et lavement. La voie orale reste le mode d’administration le plus exploité. For contributing to the assemblage of medicinal plants used against schistosomiasis in Lubumbashi and nearby, a survey was piloted in this area. This ethnobotanic survey involving 43 respondents permitted us to collect information about 61 plants used as anti-schistosomal. These species belong to 55 different genuses distributed among 32 families. The result allows us to know that these anti-schistosomial species are also used in 37 indications, including intestinal worms and malaria. Many parts of these species (bark of roots and stalks, leaves, fruits, seeds, rhizomes) are used in different manners (decoction, infusion, maceration, powder) to make different doses. Different manners of taking prepared medicines are employed: drinking, local application, painting, vapor bath, purgative. Drinking the product remains the most common way of administration.